Podcast: BD’s Polen Pursues ‘True North’ Path To High-Value Growth

With 17 M&A successes to date, BD CEO pledges to build and simplify

In this Medtech Insight special podcast recorded in June, BD’s chief executive since January 2020, Tom Polen, describes how he has built on the legacy of his predecessor to ensure the $20bn company he now heads can grow sustainably to meet the changing demands of the health care market and the modern challenges medtech managers must face.

Shutterstock

More from In Vitro Diagnostics

More from Diagnostics